StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) income statement

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$28.96−0.08 (-0.28%)

Close on Nov 18, 2026Market cap $3.42BP/E 8.1Yield –

Supernus, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
85.0%
Operating margin
40.6%
Net margin
32.8%
Return on equity, FY2025
-96.6%

Financial strength

Current ratio
0.61
Debt to equity
-8.13
Debt to assets
36.6%
Cash to current liabilities
23.4%

Valuation

P/E ratio
8.1
Price to sales
2.49
Price to book
–
Dividend yield
–

See a number that looks wrong?